Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPensionProperty, Plant & Equipment (Net)Raw MaterialsRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Growth Metrics
Income Statement
Others
Ratios

Fresenius Medical Care AG (FMCQF) Common Equity (2016 - 2025)

Fresenius Medical Care AG has reported Common Equity over the past 17 years, most recently at $16.6 billion for Q4 2025.

  • Quarterly results put Common Equity at $16.6 billion for Q4 2025, down 1.33% from a year ago — trailing twelve months through Dec 2025 was $16.6 billion (down 1.33% YoY), and the annual figure for FY2025 was $16.6 billion, down 1.33%.
  • Common Equity for Q4 2025 was $16.6 billion at Fresenius Medical Care AG, down from $16.9 billion in the prior quarter.
  • Over the last five years, Common Equity for FMCQF hit a ceiling of $16.9 billion in Q4 2024 and a floor of $15.8 billion in Q4 2022.
  • Median Common Equity over the past 5 years was $16.0 billion (2021), compared with a mean of $16.2 billion.
  • Biggest five-year swings in Common Equity: rose 8.77% in 2021 and later dropped 1.44% in 2022.
  • Fresenius Medical Care AG's Common Equity stood at $16.0 billion in 2021, then dropped by 1.44% to $15.8 billion in 2022, then increased by 1.21% to $16.0 billion in 2023, then grew by 5.63% to $16.9 billion in 2024, then dropped by 1.33% to $16.6 billion in 2025.
  • The last three reported values for Common Equity were $16.6 billion (Q4 2025), $16.9 billion (Q4 2024), and $16.0 billion (Q4 2023) per Business Quant data.